We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Image: Blue represents nuclei and pink represents dead or dying cells. Bottom right: Cells are overexpressing the BIRC3 variant which is seen in green. (Photo courtesy of The Hospital for Sick Children)

Genetic Marker Supports Anti-TNF Therapy Selection in Crohn’s Disease

New findings identify Crohn’s-linked genetic changes that may help stratify patients and guide anti-TNF therapy. More...
25 Jun 2026
Image: An uncertainty‑aware framework strengthens AI reliability for cancer histology subtyping (Image credit: Shutterstock)

Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping

An uncertainty-aware AI approach boosts pathology, flagging out-of-scope inputs and meeting accuracy targets in cancer subtyping. More...
25 Jun 2026
Image: Volition’s Nu.Q NETs test detects markers associated with neutrophil extracellular traps, which are released during NETosis and linked to sepsis and other acute and chronic disorders (Image credit: iStock)

Collaboration Aims to Broaden Access to NETosis-Linked Disease Testing

VolitionRx announced a collaboration with Sysmex Corporation to optimize Volition’s Nu.Q NETs H3.1 assay on the Sysmex platform.  More...
25 Jun 2026
Image: Findings showed that the Stockholm3 blood test detected more clinically significant prostate cancers than PSA testing without increasing unnecessary testing (Image credit: 123RF)

Blood Test Detects More High-Risk Prostate Cancers Than PSA

A new blood test detects more aggressive prostate cancers than PSA without increasing unnecessary testing. More...
24 Jun 2026
Image: Biomarker testing is critical for lung cancer therapy selection, yet ordering delays mean biopsy-to-result turnaround still averages about 27 days, according to a new study (image credit: Shutterstock)

Study Highlights Biomarker Testing Delays in Lung Cancer Care

New findings highlight ordering delays as main driver of 27-day biopsy-to-biomarker turnaround, risking delayed targeted therapy. More...
24 Jun 2026
Image: Hematopoietic stem cells (white), which produce all blood cells in the body, seen alongside blood cells (blue and red) in the bone marrow. (Image credit: Brian Heubel, Passegué laboratory, Columbia Stem Cell Initiative)

Single-Cell Analysis Mapping Links Inflammation Response to Acute Myeloid Leukemia

New findings reveal a single switch for emergency myelopoiesis and tools that map dynamics, linking AML signatures to prognosis. More...
24 Jun 2026
Image: The findings represent an important precision oncology milestone, independently confirming that endocrine activity in HR+/HER2− breast tumors can predict sensitivity to specific chemotherapy approaches (Image Credit: Adobe Stock)

Genomic Test Guides Taxane-Based Chemotherapy Selection in Breast Cancer

A new test quantifies tumor endocrine activity to predict which HR+/HER2− tumors benefit from weekly paclitaxel. More...
24 Jun 2026
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Repetitive Pipette
VWR® Stepper Pro
Electrolyte Analyzer
BKE-B
Copyright © 2000-2026 Globetech Media. All rights reserved.